Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

GoPro Inc GPRO

GoPro, Inc. provides cameras, mountable and wearable accessories, and subscription and services in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides HERO13 Black, HERO12 Black, HERO11 Black, HERO10 Black, HERO, and MAX cameras; Premium and Premium+ subscription, which are subscription services that include cloud storage for its content; and Quik subscription, a subscription service in total addressable market to those who value organizing the visual moments of their lives with footage from any phone or camera. It also offers mobile and web applications, and desktop plugins that provide a media workflow for archiving, editing, multi-clip story creation, and sharing content on the fly; and a lifestyle gear lineup that melds its signature design and versatility across a line of bags, backpacks, and cases, as well as a line of t-shirts, hats, and other soft goods. In addition, the company provides mounts and accessories; equipment-based mounts com...


NDAQ:GPRO - Post by User

<< Previous
Bullboard Posts
Next >>
User Avatar Image
(0)
•••
  • NatashaRomanX
Post by NatashaRomanon Jun 03, 2022 3:27am
139 Views
Post# 34728632

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance


FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets clearance
 
FSD Pharma Inc CEO Anthony Durkacz told Proactive that the company is ready to proceed with the planned Phase 2 clinical trial of its FSD-201 drug candidate as soon as it gets the go-ahead from the US Food and Drug Administration and Health Canada. That's after submitting Investigational New Drug (IND) applications to the two bodies this week. Armed with cash of about $50 million following the $16.4 million disposal of its former cannabis production facility in Ontario, Durkacz said FSD is also moving full-steam ahead on its two other drug candidates and may look for other opportunities. A special dividend may also be on the cards, he added.


<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities